X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Emily Donaldson

Emily Donaldson is a senior director for policy and research at PhRMA, working with PhRMA’s state and federal policy teams to improve patient access to medicines and encourage alignment between state and federal policies. Prior to joining PhRMA, she worked for the Blue Cross and Blue Shield Association focusing on state health policy. Having recently moved to Tokyo, Japan, Emily enjoys exploring and learning about her new home with her husband and two sons.

Recent Posts

Addressing data challenges to improve health equity

By Emily Donaldson  |    September 17, 2021
The COVID-19 pandemic has shed light on the ways that systemic racism pervades nearly every facet of life – especially within our health care system. The biopharmaceutical industry is dedicated to...   Read More

Paper finds gaps in health data are a barrier to health equity

By Emily Donaldson  |    January 11, 2021
COVID-19 has laid bare racial disparities in the United States health system. For example, COVID-19 cases among Native Hawaiian / Pacific Islanders are up to 2.5 times higher as compared to...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates